Effects of statins on regeneration of olfactory epithelium

American Journal of Rhinology and Allergy

Volumn 24, Issue 2, 2010, Pages 121-125

  Kim, Hyo Yeol ^a   Dhong, Hun Jong ^a   Min, Jin Young ^a   Jung, Young Gi ^a   Chung, Seung Kyu ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

3 methylindole; Anosmia; Hydroxymethylglutaryl CoA reductase inhibitors; Immunohistochemistry; Neuroregenesis; Olfaction disorders; Olfactory receptor neurons; Olfactotoxicant; Statins; Steroids

Indexed keywords

ATORVASTATIN; CYCLINE; EOSIN; GENE PRODUCT; HEMATOXYLIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PREDNISOLONE; SKATOLE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NOSE DISEASE; OLFACTORY EPITHELIUM; OLFACTORY EPITHELIUM DAMAGE; RAT; SMELLING DISORDER; STOMACH TUBE; THICKNESS; TISSUE REGENERATION;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; HEPTANOIC ACIDS; OLFACTORY MUCOSA; PREDNISOLONE; PROLIFERATING CELL NUCLEAR ANTIGEN; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION; SKATOLE; UBIQUITIN THIOLESTERASE;

EID: 77950900819     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2010.24.3455     Document Type: Article

References (28)

1. Cullen MM, and Leopold DA. Disorders of smell and taste. Med Clin North Am 83:57-74, 1999.
2. Dhong HJ, Kim HY, and Ha BS. Histologic changes to olfactory epithelium in hypothyroid rats. Otolaryngol Head Neck Surg 129:24-32, 2003. (Pubitemid 37391040)
3. Bramerson A, Johansson L, Ek L, et al. Prevalence of olfactory dysfunction: The Skovde population-based study. Laryngoscope 114: 733-737, 2004. (Pubitemid 38548788)
4. Temmel AF, Quint C, Schickinger-Fischer B, et al. Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg 128:635-641, 2002. (Pubitemid 34665843)
5. Dubuc G, Chamberland A, Wassef H, et al. Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 24:1454-1459, 2004. (Pubitemid 39050440)
6. Jung KH, Chu K, Jeong SW, et al. HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage. Stroke 35:1744-1749, 2004. (Pubitemid 38823658)
7. Sarkey JP, Richards MP, and Stubbs EB Jr. Lovastatin attenuates nerve injury in an animal model of Guillain-Barre syndrome. J Neurochem 100:1265-1277, 2007. (Pubitemid 46246409)
8. Dhong HJ, Chung SK, and Doty RL. Estrogen protects against 3-methylindole-induced olfactory loss. Brain Res 824:312-315, 1999.
9. Setzer AK, and Slotnick B. Disruption of axonal transport from olfactory epithelium by 3-methylindole. Physiol Behav 65:479-487, 1998. (Pubitemid 29015764)
10. Peele DB, Allison SD, Bolon B, et al. Functional deficits produced by 3-methylindole-induced olfactory mucosal damage revealed by a simple olfactory learning task. Toxicol Appl Pharmacol 107:191-202, 1991.
11. Turk MA, Henk WG, and Flory W. 3-Methylindole-induced nasal mucosal damage in mice. Vet Pathol 24:400-403, 1987.
12. Jafek BW, Moran DT, Eller PM, et al. Steroid-dependent anosmia. Arch Otolaryngol Head Neck Surg 113:547-549, 1987.
13. Lee CH, Mo JH, Shim SH, et al. Effect of ginkgo biloba and dexamethasone in the treatment of 3-methylindole-induced anosmia mouse model. Am J Rhinol 22:292-296, 2008.
14. Stevens MH. Steroid-dependent anosmia. Laryngoscope 111:200-203, 2001.
15. Kratskin IL, Kimura Y, Hastings L, and Doty RL. Chronic dexamethasone treatment potentiates insult to olfactory receptor cells produced by 3-methylindole. Brain Res 847:240-246, 1999.
16. Miller MA, and O'Bryan MA. Ultrastructural changes and olfactory deficits during 3-methylindole-induced olfactory mucosal necrosis and repair in mice. Ultrastruct Pathol 27:13-21, 2003.
17. Wiethoff AJ, Harkema JR, Koretsky AP, and Brown WE. Identification of mucosal injury in the murine nasal airways by magnetic resonance imaging: Site-specific lesions induced by 3-methylindole. Toxicol Appl Pharmacol 175:68-75, 2001.
18. Ge Y, Tsukatani T, Nishimura T, et al. Cell death of olfactory receptor neurons in a rat with nasosinusitis infected artificially with Staphylococcus. Chem Senses 27:521-527, 2002.
19. Oikawa T, Saito H, Taniguchi K, and Taniguchi K. Immunohistochemical studies on the differential maturation of three types of olfactory organs in the rats. J Vet Med Sci 63:759-765, 2001. (Pubitemid 33701554)
20. Johnson EW. Immunocytochemical characteristics of cells and fibers in the nasal mucosa of young and adult macaques. Anat Rec 259:215-228, 2000.
21. Weber R, Raschka C, and Bonzel T. Toxic drug-induced hyposmia with lovastatin. Laryngorhinootologie 71:483-484, 1992.
22. Sparks DL, Petanceska S, Sabbagh M, et al. Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT). Curr Alzheimer Res 2:527-539, 2005.
23. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. (4S). Lancet 344:1383-1389, 1994.
24. Seyfried D, Han Y, Lu D, et al. Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats. J Neurosurg 101:104-107, 2004. (Pubitemid 38808468)
25. Chen J, Zhang ZG, Li Y, et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 53:743-751, 2003. (Pubitemid 36622511)
26. Daw MI, Bortolotto ZA, Saulle E, et al. Phosphatidylinositol 3 kinase regulates synapse specificity of hippocampal long-term depression. Nat Neurosci 5:835-836, 2002. (Pubitemid 34976644)
27. Johnson-Anuna LN, Eckert GP, Keller JH, et al. Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J Pharmacol Exp Ther 312:786-793, 2005.
28. Schmechel A, Grimm M, El-Armouche A, et al. Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects. Cardiovasc Res 82:100-106, 2009.